In an interview by Xtalks, company leaders at Samsung Bioepis, Ilsun Hong and Thomas Newcomer, discuss the company's advancements in the biosimilar industry. They discuss the FDA approval for both high- and low-concentration formulations of their adalimumab biosimilar and the...
Trending Articles
More Pages to Explore .....